Bioelectric patterns—spatiotemporal voltage gradients across cells and tissues—serve as "cognitive glue" for collective cellular intelligence, encoding target morphologies and guiding regeneration, development, and maintenance. In Michael Levin's framework, these patterns aren't static; they're dynamic prepatterns that can be injected or perturbed to rewrite biological goals, countering aging as "loss of goal-directedness" (e.g., via brief interventions that create permanent changes). Patterns involve membrane voltage (Vmem) levels, ion fluxes (e.g., H+, K+, Cl-), and gap junction communication, often visualized as color-coded gradients (e.g., hyperpolarized regions in blue, depolarized in red). Injection methods: pharmacological (ion channel drugs), optogenetic (light-activated channels), or electrical (microelectrodes).

Extrapolating from Levin's examples (e.g., planarian polarity rewriting, frog limb induction), here are possible bio patterns to inject for therapeutic applications. These are speculative extensions based on known mechanisms, bounded by ethical/safety constraints (e.g., avoid oncogenic risks from over-depolarization). Each includes a target system, pattern description, injection method, and expected outcome.

1. **Limb Regeneration Pattern (e.g., for Amputees)**  
   - **Description**: A cranio-caudal voltage gradient (hyperpolarized at stump tip, depolarized proximally) to encode "grow limb" setpoint. Pattern: ~ -60 mV to -90 mV linear drop over 1-2 mm, with lateral symmetry via K+ flux.  
   - **Injection Method**: Optogenetic channels (ChR2 for depolarization) or H,K-ATPase inhibitors (e.g., SCH-28080) applied briefly (24-48 hours) post-injury.  
   - **Outcome**: Triggers dedifferentiation and blastema formation, regenerating functional limb (seen in frogs; potential for mammals with scaling).  
   - **Visual**:  (Bioelectric gradient in regenerating frog limb.)

2. **Neural Repair Pattern (e.g., for Spinal Cord Injury)**  
   - **Description**: Rostro-caudal depolarization wave ( -40 mV peak at injury site, fading to -70 mV distally) to guide axon regrowth, with transverse Cl- gradients for symmetry.  
   - **Injection Method**: Ivermectin (chloride channel opener) or electrical microstimulation for 1-2 weeks.  
   - **Outcome**: Restores connectivity, potentially recovering motor function (extrapolated from planarian nerve rewiring).  
   - **Visual**:  (Voltage pattern in neural regeneration simulation.)

3. **Anti-Aging Homeostasis Pattern (e.g., for Tissue Maintenance)**  
   - **Description**: Uniform hyperpolarization (-80 mV baseline) with oscillatory K+ pulses (1-5 Hz) to sustain morphostatic memory, preventing drift.  
   - **Injection Method**: Systemic monensin (Na+ ionophore) or gap junction enhancers (e.g., retinoic acid) for chronic low-dose modulation.  
   - **Outcome**: Maintains cellular collective goals, slowing senescence (inspired by NCA models where sustained patterns halt degradation).  
   - **Visual**:  (Homeostatic bioelectric field in mature tissue.)

4. **Cancer Suppression Pattern (e.g., for Tumor Reprogramming)**  
   - **Description**: Localized hyperpolarization (-90 mV in tumor core) with surrounding depolarization ring to enforce "normal tissue" setpoint.  
   - **Injection Method**: Voltage-gated channel blockers (e.g., valproic acid) targeted via nanoparticles.  
   - **Outcome**: Reintegrates rogue cells into collective, reversing malignancy (Levin's planarian tumor experiments).  
   - **Visual**:  (Bioelectric reprogramming of cancer cells.)

5. **Organ Rejuvenation Pattern (e.g., for Heart or Liver)**  
   - **Description**: Radial voltage gradient (depolarized center to hyperpolarized periphery) with 0.5-1 Hz oscillations to reset developmental goals.  
   - **Injection Method**: Electroporation or CRISPR-optogenetics for site-specific ion channel expression.  
   - **Outcome**: Restores youthful function, reducing fibrosis (extrapolated from frog heart regeneration).  
   - **Visual**:  (Organ-level bioelectric pattern map.)

These patterns could be simulated in NCA models or tested in vitro (e.g., planaria) before scaling to mammals. Safety: Brief perturbations suffice for permanent changes, minimizing risks. Extrapolations assume ethical trials; consult Levin's protocols for precision.